Bioconcentration of ibuprofen in fathead minnow (Pimephales promelas) and channel catfish (Ictalurus punctatus)

Chemosphere

Volumn 84, Issue 10, 2011, Pages 1371-1377

  Nallani, Gopinath C ^a   Paulos, Peter M ^a   Constantine, Lisa A ^b   Venables, Barney J ^a   Huggett, Duane B ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Bioconcentration; Channel catfish; Fathead minnow; Fish; Ibuprofen; Pharmaceuticals

Indexed keywords

DRUG PRODUCTS; FISH; HISTOLOGY; METABOLITES; RISK ASSESSMENT; TISSUE;

BIO-CONCENTRATION FACTORS; BIOCONCENTRATION; BIOCONCENTRATION TESTS; CHANNEL CATFISH; FATHEAD MINNOW; IBUPROFEN; PHARMACEUTICAL PRODUCTS; SCREENING APPROACHES;

BIOACCUMULATION;

BIOCONCENTRATION FACTOR; DRUG METABOLITE; IBUPROFEN; UNCLASSIFIED DRUG;

BIOACCUMULATION; CHEMICAL POLLUTANT; DRUG; FRESHWATER ECOSYSTEM; LABORATORY METHOD; METABOLITE; PLASMA; POLLUTION EXPOSURE; TELEOST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUATIC ENVIRONMENT; ARTICLE; CHANNEL CATFISH; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG SCREENING; DRUG TISSUE LEVEL; DRUG UPTAKE; ENVIRONMENTAL EXPOSURE; FEMALE; GILL; KIDNEY; MALE; NONHUMAN; PIMEPHALES PROMELAS; SCREENING TEST; SPECIES COMPARISON; STANDARD; TOXICOKINETICS;

ICTALURUS PUNCTATUS; PIMEPHALES PROMELAS;

EID: 79961209905     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2011.05.008     Document Type: Article

References (33)

1. ACD, 2006. ACD/PhysChem Suite, version 10.00, Advanced Chemistry Development, Inc., Toronto, ON, Canada. http://www.acdlabs.com.
2. Ankley G.T., Villeneuve D.L. The fathead minnow in aquatic toxicology: past, present and future. Aquat. Toxicol. 2006, 78:91-102.
3. Arnot J.A., Gobas F.A.P.C. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessment for organic chemicals in fish. Environ. Rev. 2006, 14:257-297.
4. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
5. Barnes K.K., Kolpin D.W., Furlong E.T., Zaugg S.D., Meyer M.T., Barber L.B. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States - I) groundwater. Sci. Total Environ. 2008, 402:192-200.
6. Buser H.R., Poiger T., Müller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33:2529-2535.
7. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107:907-938.
8. David A., Pancharatna K. Developmental anomalies induced by a non-selective COX inhibitor (ibuprofen) in zebrafish (Danio rerio). Environ. Toxicol. Pharmacol. 2009, 27:390-395.
9. Davies N.M. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin. Pharmacokinet. 1998, 34:101-154.
10. EC - Environment Canada, 2001. Strategy for a future chemicals policy. White Paper. European Commission, Brussels, BE, p. 32.
11. EMEA - European Medicines Agency, 2006. Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00. London, D.R.
12. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ. Sci. Technol. 2010, 44:2661-2666.
13. Flippin J.L., Huggett D., Foran C.M. Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat. Toxicol. 2007, 81:73-78.
14. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer T.M., Zaugg S.D., Barber L.B., Thurman M.E. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) untreated drinking water sources. Sci. Total Environ. 2008, 402:201-216.
15. Gomez C., Constantine L., Moen M., Vaz A., Huggett D.B. The influence of gill and liver metabolism on the predicted bioconcentration in fish. Chemosphere. 2010, 81:1189-1195.
16. Gomez C., Constantine L., Moen M., Vaz A., Huggett D.B. Ibuprofen metabolism in the liver and gill of rainbow trout, Oncorhynchus mykiss. Bull. Environ. Contam. Toxicol. 2011, 86:247-251.
17. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 2008, 42:5807-5813.
18. Han S., Choi K., Kim J., Ji K., Kim S., Ahn B., Yun J., Choi K., Khim J.S., Zhang X., Giesy J.P. Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater cladocerans Daphnia magna and Moina macrocopa. Aquat. Toxicol. 2010, 98:256-264.
19. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 2003, 9:1789-1799.
20. Huggett D.B., Ericson J.F., Cook J.C., Williams R.T. Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. Pharmaceuticals in the Environment: Sources, Fate and Effects and Risks 2004, 373-385. Springer, Berlin, Germany. K. Kümmereer (Ed.).
21. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
22. Metcalfe C.D., Miao X.S., Koening B.G., Struger J. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22:2872-2880.
23. Newman M.C. Quantitative Methods in Aquatic Ecotoxicology 1995, CRC, Boca Raton, FL, USA.
24. OECD, 1996. OECD Guidelines for the Testing of Chemicals - Section 3 - Degradation and Accumulation Test TG No. 305. Bioconcentration: Flow-through Fish Test. Organization for Economic Co-operation and Development.
25. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products (PPCPs) in fish: results of a national pilot study in the US. Environ. Toxicol. Chem. 2009, 28:2587-2597.
26. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I. Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
27. Springer T.A., Guiney P.D., Krueger H.O., Jaber M.J. Assessment of an approach to estimating aquatic bioconcentration factors using reduced sampling. Environ. Toxicol. Chem. 2008, 27:2271-2280.
28. SRC, 2009. Syracuse Research Corporation Environmental Science Database. SRC Physical Properties Database. http://www.syrres.com/what-we-do/databaseforms.aspx?id=386.
29. UNEP, 2001. Final act of the conference of plenipotentiaries on the Stockholm convention on persistent organic pollutants. In: Proceeding of the Conference of Plenipotentiaries on the Stockholm Convention on Persistent Organic Pollutants. United Nations Environmental Program, Stockholm, Sweden, 22-23, May 2001.
30. US EPA 1986. Method Detection Limit (MDL) in Title 40 Code of Federal Regulations Part 136 (40 CFR 136, Appendix B, revision 1.11).
31. USEPA, 2003. Fact sheet: Methodology for deriving ambient water quality criteria for the protection of human health (2000): Technical Support Document, Vol. 2, Development of national bioaccumulation factors. EPA 822/F-03/014.
32. US EPA, 2009. Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.00. United States Environmental Protection Agency, Washington, DC, USA.
33. Weisbrod A.V., Sahi J., Segner H., James M.O., Nichols J., Schultz I., Erhardt S., Cowan-Ellsberry C., Bonnell M., Hoeger B. The state of in vitro science for use in bioaccumulation assessments for fish. Environ. Toxicol. Chem. 2009, 28:86-96.